243 related articles for article (PubMed ID: 17198274)
21. Immunophenotyping of interstitial infiltrate does not distinguish between BK virus nephropathy and acute cellular rejection.
Rogers NM; Russ GR; Cooper J; Coates PT
Nephrology (Carlton); 2009 Feb; 14(1):118-22. PubMed ID: 19143944
[TBL] [Abstract][Full Text] [Related]
22. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization.
Wu GD; He Y; Chai NN; Toyoda M; Dunn R; Kehry MR; Klein AS; Jordan SC
Transpl Immunol; 2008 Jul; 19(3-4):178-86. PubMed ID: 18595710
[TBL] [Abstract][Full Text] [Related]
23. Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d.
Kayler LK; Kiss L; Sharma V; Mohanka R; Zeevi A; Girnita A; Shapiro R; Randhawa PS
Transplantation; 2008 Mar; 85(6):813-20. PubMed ID: 18360261
[TBL] [Abstract][Full Text] [Related]
24. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
Ranjan P; Nada R; Jha V; Sakhuja V; Joshi K
Nephrol Dial Transplant; 2008 May; 23(5):1735-41. PubMed ID: 18065805
[TBL] [Abstract][Full Text] [Related]
25. Interleukin 2 receptor expression in renal biopsies and the diagnosis of acute allograft rejection.
Mathan A; Kuruvilla S; Abraham G
Indian J Pathol Microbiol; 2006 Jan; 49(1):12-6. PubMed ID: 16625964
[TBL] [Abstract][Full Text] [Related]
26. Characterization of intra-graft B cells during renal allograft rejection.
Zarkhin V; Kambham N; Li L; Kwok S; Hsieh SC; Salvatierra O; Sarwal MM
Kidney Int; 2008 Sep; 74(5):664-73. PubMed ID: 18547992
[TBL] [Abstract][Full Text] [Related]
27. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
Carstens J; Ozbay A; Tørring C; Hansen HE
Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
[TBL] [Abstract][Full Text] [Related]
28. CD103 mRNA levels in urinary cells predict acute rejection of renal allografts.
Ding R; Li B; Muthukumar T; Dadhania D; Medeiros M; Hartono C; Serur D; Seshan SV; Sharma VK; Kapur S; Suthanthiran M
Transplantation; 2003 Apr; 75(8):1307-12. PubMed ID: 12717221
[TBL] [Abstract][Full Text] [Related]
29. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients.
Matignon M; Tagnaouti M; Audard V; Dahan K; Lang P; Grimbert P
Transplant Proc; 2007 Oct; 39(8):2565-7. PubMed ID: 17954175
[TBL] [Abstract][Full Text] [Related]
30. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
[TBL] [Abstract][Full Text] [Related]
31. Proliferating cell nuclear antigen (PCNA) as a diagnostic marker of acute cellular rejection in routinely processed biopsies of renal allografts.
Thom M; Palmer A; Cattell V; Cook T
Nephrol Dial Transplant; 1994; 9(2):153-5. PubMed ID: 7910676
[TBL] [Abstract][Full Text] [Related]
32. Expression of the chemokine receptor CXCR3 in human renal allografts--a prospective study.
Hoffmann U; Segerer S; Rümmele P; Krüger B; Pietrzyk M; Hofstädter F; Banas B; Krämer BK
Nephrol Dial Transplant; 2006 May; 21(5):1373-81. PubMed ID: 16421159
[TBL] [Abstract][Full Text] [Related]
33. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
Lee PC; Zhu L; Terasaki PI; Everly MJ
Transplantation; 2009 Aug; 88(4):568-74. PubMed ID: 19696641
[TBL] [Abstract][Full Text] [Related]
34. Quilty effect areas are frequently associated with endocardial C4d deposition.
Cano LC; Arteta AA; Fernández R; García-Asenjo JA; Hernández S; Fernández D; Arias LF
J Heart Lung Transplant; 2008 Jul; 27(7):775-9. PubMed ID: 18582808
[TBL] [Abstract][Full Text] [Related]
35. Acute renal allograft rejections with major interstitial oedema and plasma cell-rich infiltrates: high gamma-interferon expression and poor clinical outcome.
Desvaux D; Le Gouvello S; Pastural M; Abtahi M; Suberbielle C; Boeri N; Rémy P; Salomon L; Lang P; Baron C
Nephrol Dial Transplant; 2004 Apr; 19(4):933-9. PubMed ID: 15031352
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of cytotoxic T-lymphocytes and CD40 in biopsies with early renal allograft rejection.
Mengel M; Mueller I; Behrend M; von Wasielewski R; Radermacher J; Schwarz A; Haller H; Kreipe H
Transpl Int; 2004 Jul; 17(6):293-300. PubMed ID: 15221125
[TBL] [Abstract][Full Text] [Related]
37. Acute cellular rejection.
Ganji MR; Broumand B
Iran J Kidney Dis; 2007 Oct; 1(2):54-6. PubMed ID: 19363277
[TBL] [Abstract][Full Text] [Related]
38. Influence of time of rejection on long-term graft survival in renal transplantation.
Opelz G; Döhler B;
Transplantation; 2008 Mar; 85(5):661-6. PubMed ID: 18337655
[TBL] [Abstract][Full Text] [Related]
39. C4d-positive chronic rejection: a frequent entity with a poor outcome.
David-Neto E; Prado E; Beutel A; Ventura CG; Siqueira SA; Hung J; Lemos FB; de Souza NA; Nahas WC; Ianhez LE; David DR
Transplantation; 2007 Dec; 84(11):1391-8. PubMed ID: 18091514
[TBL] [Abstract][Full Text] [Related]
40. Rituximab removes intrarenal B cell clusters in patients with renal vascular allograft rejection.
Steinmetz OM; Lange-Hüsken F; Turner JE; Vernauer A; Helmchen U; Stahl RA; Thaiss F; Panzer U
Transplantation; 2007 Oct; 84(7):842-50. PubMed ID: 17984836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
